Article: Islet cell antibody heterogeneity among type 1 (insulin-dependent) diabetic patients

Conventional detection of islet cell antibodies is based on indirect immunofluorescence performed on frozen human pancreas sections. The number and nature of epitopes recognized by antibodies detected by such techniques are unknown. To determine the existence of heterogeneous fluorescence patterns of islet cell antibodies on pancreatic sections, we selected two sera showing a distinctive granular fluorescence. We then tested random sera from patients with Type 1 (insulin-dependent) diabetes mellitus for their ability to block ultimate binding of fluorescein isothiocyanate-labelled immunoglobulins purified from these two sera with a characteristic granular pattern. Among 102 subjects with recent-onset Type 1 diabetes, 79 had detectable anti-islet cell antibodies; 21 showed complete blockade of the binding to islets of granular fluorescein isothiocyanate-labelled immunoglobulins. The majority of these 21 patients were women carrying a DR3 non-DR4 DQB1*0201 allele, with under-representation of DRB1*0402 and 0405. Discrimination between islet cell antigenic specificities may help in identifying islet cell autoantibodies in autoimmune Type 1 diabetes.

Citing Articles

Anti-GAD monoclonal antibody delays the onset of diabetes mellitus in NOD mice.

Menard V, Jacobs H, Jun H, Yoon J, Kim S Pharm Res. 1999; 16(7):1059-66.

PMID: 10450931 DOI: 10.1023/a:1018939900961.

Association between HLA and islet cell antibodies in diabetic patients with a mitochondrial DNA mutation at base pair 3243.

Kobayashi T, Oka Y, Katagiri H, Falorni A, Kasuga A, Takei I Diabetologia. 1996; 39(10):1196-200.

PMID: 8897007 DOI: 10.1007/BF02658506.

Subtype of islet cell antibodies and slowly progressive beta-cell failure.

Kobayashi T, Nakanishi K, Murase T, Kosaka K Diabetologia. 1993; 36(1):92.

PMID: 8436262 DOI: 10.1007/BF00399102.

Quantification of human cytoplasmic islet-cell antibodies which cross-react with mouse pancreas: a follow-up study in type 1 (insulin-dependent) diabetic patients and in first-degree relatives.

Sai P, Elmansour A, Audrain M, Charbonnel B, Bardet S Diabetologia. 1993; 36(8):778-84.

PMID: 8405747 DOI: 10.1007/BF00401151.

Combined analysis of islet cell antibodies which cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in subjects at risk for IDDM.

Chaillous L, Delamaire M, Elmansour A, Maugendre D, Rohmer V, Joseph M Diabetologia. 1994; 37(5):491-9.

PMID: 8056187 DOI: 10.1007/s001250050137.

References

1.

Bottazzo G, Florin-Christensen A, Doniach D . Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet. 1974; 2(7892):1279-83. DOI: 10.1016/s0140-6736(74)90140-8. View

2.

Bonifacio E, Bingley P, Shattock M, Dean B, Dunger D, Gale E . Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet. 1990; 335(8682):147-9. DOI: 10.1016/0140-6736(90)90013-u. View

3.

Gianani R, Pugliese A, Bonner-Weir S, Shiffrin A, Soeldner J, Erlich H . Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes. Diabetes. 1992; 41(3):347-53. DOI: 10.2337/diab.41.3.347. View

4.

Bonifacio E, Boitard C, Gleichmann H, Shattock M, Molenaar J, Bottazzo G . Assessment of precision, concordance, specificity, and sensitivity of islet cell antibody measurement in 41 assays. Diabetologia. 1990; 33(12):731-6. DOI: 10.1007/BF00400345. View

5.

Tiercy J, Goumaz C, MACH B, Jeannet M . Application of HLA-DR oligotyping to 110 kidney transplant patients with doubtful serological typing. Transplantation. 1991; 51(5):1110-4. DOI: 10.1097/00007890-199105000-00034. View

Islet Cell Antibody Heterogeneity Among Type 1 (insulin-dependent) Diabetic Patients